| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Feb 2026 | 3 Feb 2026 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve Q3-FY 26 Unaudited Financial Results Please find attached the Q3 and Nine Months FY26 Results (As per BSE Announcement dated on: 10.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited financial results for Q-2 FY26. Q2 FY26 Financial Results along with limited review report thereon Q2 FY26 Financial Results along with Limited Review Report thereon (As Per BSE Announcement Dated on:14.11.2025) | ||
| Board Meeting | 6 Aug 2025 | 1 Aug 2025 |
| Morepen Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve unaudited financial results for Q-1 FY26 Q1 FY26 Results and Others Please find attached the Q1-FY 26 Unaudited Financial Results (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 21 Jun 2025 | 21 Jun 2025 |
| Re-appointment of Mrs. (Dr.) Savita as an Independent Director for a second term of 5 years | ||
The venture will follow a 50:50 shareholding structure, with Morepen Medipath indirectly holding a 30% stake.
With this approval, Morepen Laboratories aims to strengthen its presence in China, which is one of the world’s largest pharmaceutical markets.
Developed from scratch, this drug offers an inexpensive and superior alternative to current treatments, making it accessible to hundreds of millions of patients.
Here are some of the stocks that may see significant price movement today: Tata Motors, ITC, Kalyan Jewellers, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
